SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-22-213610
Filing Date
2022-08-05
Accepted
2022-08-05 16:17:00
Documents
2
Group Members
F2 BIOSCIENCE AV 2022 LLCF2 CAPITAL I 2020 LLCF2 MC, LLCF2 MG LTD.F2-TPO INVESTMENTS, LLCGLOBEWAYS HOLDINGS LTD.MORANA JOVAN-EMBIRICOS

Document Format Files

Seq Description Document Type Size
1 SC 13D d380321dsc13d.htm SC 13D 166174
2 EX-99.1 d380321dex991.htm EX-99.1 8135
  Complete submission text file 0001193125-22-213610.txt   176138
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Subject) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91605 | Film No.: 221141082
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SINGER, MCKEON INC. 8 W 38TH ST. STE. 1001 NEW YORK NY 10018
Business Address PO BOX 3175 ROAD TOWN TORTOLA D8 VG1110 212-490-0060
Globeways Holdings II Ltd (Filed by) CIK: 0001768161 (see all company filings)

IRS No.: 831182867 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D